have be treat with felbamate or vigabatrin within the past 6 month prior to screening if a subject have be previously treat with vigabatrin a visual perimetry test prior to screening or within the past 6 month must show normal visual field or no worsening of recognized visual field abnormality a compare with prior to vigabatrin treatment 